(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 4.18% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.
Icu Medical's revenue in 2026 is $2,159,602,000.On average, 10 Wall Street analysts forecast ICUI's revenue for 2026 to be $55,890,729,930, with the lowest ICUI revenue forecast at $53,390,026,130, and the highest ICUI revenue forecast at $58,166,370,388. On average, 10 Wall Street analysts forecast ICUI's revenue for 2027 to be $58,366,426,692, with the lowest ICUI revenue forecast at $55,390,589,170, and the highest ICUI revenue forecast at $61,542,320,518.
In 2028, ICUI is forecast to generate $61,142,207,910 in revenue, with the lowest revenue forecast at $57,541,194,438 and the highest revenue forecast at $65,143,333,990.